We are live on ! Find out more
FBRX icon

Forte Biosciences
FBRX

27 hedge funds and large institutions have $42.1M invested in Forte Biosciences in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 13 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

572% more capital invested

Capital invested by funds: $6.25M → $42.1M (+$35.8M)

1.01% more ownership

Funds ownership: 0.06% → 1.07% (+1%)

46% less funds holding

Funds holding: 50 → 27 (-23)

69% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 13

77% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 30

Holders
27
Holders Change
-23
Holders Change %
-46%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
13
Closed
30
Calls
$548K
Puts
–
Net Calls
+$548K
Net Calls Change
+$498K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$17.5M
2
O
OrbiMed
New York
+$17M
3
FAM
Fred Alger Management
New York
+$12.9M
4
MA
MYDA Advisors
New York
+$515K
5
Jane Street
Jane Street
New York
+$182K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.11M
2
State Street
State Street
Massachusetts
-$430K
3
Morgan Stanley
Morgan Stanley
New York
-$356K
4
Northern Trust
Northern Trust
Illinois
-$248K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$117K
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
– -$63K -136 Closed
Citadel Advisors
27
Citadel Advisors
Florida
– -$56K -123 Closed
Bank of New York Mellon
28
Bank of New York Mellon
New York
– -$55K -120 Closed
N
29
Nuveen
North Carolina
– -$50K -110 Closed
BF
30
Blankinship & Foster
California
– -$49K -107 Closed
CG
31
Colony Group
Massachusetts
– -$45K -99 Closed
PPA
32
Parametric Portfolio Associates
Washington
– -$44K -95 Closed
Wells Fargo
33
Wells Fargo
California
– -$41.6K -93 -99%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
– -$39K -86 Closed
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
– -$32K -71 Closed
UBS Group
36
UBS Group
Switzerland
– -$26K -56 Closed
HLA
37
Hamilton Lane Advisors
Pennsylvania
– -$24K -53 Closed
IIA
38
IPG Investment Advisors
California
– -$24.4K -53 Closed
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
– -$21K -46 Closed
BFA
40
Beaumont Financial Advisors
Massachusetts
– -$20K -43 Closed
BP
41
BBR Partners
New York
– -$18K -39 Closed
Two Sigma Investments
42
Two Sigma Investments
New York
– -$17K -38 Closed
BCM
43
Bridgeway Capital Management
Texas
– -$16K -35 Closed
AIG
44
American International Group
New York
– -$15K -33 Closed
HF
45
HRT Financial
New York
– -$15K -33 Closed
PAG
46
Private Advisor Group
New Jersey
– -$12.1K -27 -96%
Victory Capital Management
47
Victory Capital Management
Texas
– -$10K -21 Closed
Barclays
48
Barclays
United Kingdom
– -$9K -19 Closed
JP Morgan Chase
49
JP Morgan Chase
New York
– -$8K -18 Closed
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
– -$7.91K -17 Closed
1
2
3

FBRX Hedge Fund Activity: Q2 2020 in Review

27 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q2 2020, worth a combined $42.1M — up 572% from $6.25M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of FBRX and 7 opened new positions — a net loss of 23 holders — while 13 trimmed existing stakes and 4 added.

The largest buyer was BVF Inc, opening a new position worth an estimated $17.5M. The largest seller was BlackRock, cutting an estimated $1.11M.

  • 27 institutional investors held Forte Biosciences (FBRX) as of Q2 2020, down from 50 in Q1 2020.
  • Funds reported $42.1M of Forte Biosciences stock for Q2 2020, up 572% quarter-over-quarter.
  • 7 funds opened new Forte Biosciences positions in Q2 2020 and 30 closed out, a net change of -23 holders.
  • The largest Forte Biosciences buyer in Q2 2020 was BVF Inc, an estimated $17.5M added.
  • The largest Forte Biosciences seller in Q2 2020 was BlackRock, an estimated $1.11M sold.

Based on aggregated 13F filings for Q2 2020.